- Published on
Medicine – Syphilis: Aetiology, Transmission, Clinical Stages, Diagnosis and Treatment
1. Introduction to Syphilis
Syphilis is a chronic, systemic infectious disease caused by Treponema pallidum, a highly invasive bacterium belonging to the spirochaete group.
The infection is transmitted predominantly through sexual contact and is characterised by a series of clinical stages involving the skin, mucous membranes, lymphatic system, cardiovascular system and nervous system.
One of the most important characteristics of syphilis is its ability to remain clinically silent for prolonged periods while infection persists within the body.
Without appropriate treatment, syphilis may progress from a localised genital ulcer to disseminated infection and, in some patients, severe cardiovascular or neurological complications many years later.
Syphilis is sometimes called the great imitator because its clinical manifestations can resemble those of numerous other diseases.
2. Aetiological Agent – Treponema pallidum
The causative organism of syphilis is Treponema pallidum subspecies pallidum.
It is a thin, spiral-shaped, motile bacterium classified as a spirochaete.
The organism possesses a characteristic corkscrew-like structure that enables movement through viscous environments and host tissues.
Its thin diameter makes it difficult to visualise using conventional light microscopy and routine Gram staining.
Specialised techniques, including dark-field microscopy and certain molecular methods, can be used to detect the organism directly.
Treponema pallidum is highly adapted to human infection and is not routinely cultured using standard clinical bacteriological methods.
3. Transmission of Syphilis
Syphilis is transmitted primarily through direct contact with infectious lesions during vaginal, anal or oral sexual activity.
The organism enters the body through microscopic breaks in the skin or mucous membranes.
Transmission is particularly associated with primary and secondary syphilis because infectious organisms are abundant in mucocutaneous lesions.
Syphilis can also be transmitted vertically from a pregnant individual to the fetus through the placenta, producing congenital syphilis.
Transmission through blood transfusion is exceptionally rare in modern healthcare systems because of donor screening and blood-storage practices.
Syphilis is not transmitted through ordinary casual contact, such as sharing utensils, shaking hands or using the same toilet.
4. Incubation Period
The incubation period of syphilis is the interval between exposure to Treponema pallidum and the appearance of the first clinical lesion.
The incubation period is typically approximately three weeks, although it may range from about 10 to 90 days.
The original notes describe an incubation period of two to four weeks, which represents a common interval but does not include the full possible range.
During incubation, the organism multiplies at the site of entry and may begin spreading through lymphatic channels and the bloodstream.
The patient generally remains asymptomatic until the primary lesion develops.
5. Pathogenesis of Syphilis
Following entry through the skin or mucosa, Treponema pallidum multiplies locally and stimulates an inflammatory response.
The organism can disseminate through the lymphatic system and bloodstream relatively early in infection.
A characteristic pathological feature is endarteritis, an inflammatory process affecting the inner lining of small blood vessels.
This vascular inflammation contributes to tissue injury and the development of characteristic syphilitic lesions.
The host immune response may control visible manifestations without completely eliminating the organism.
As a result, syphilis can enter a prolonged latent phase and, if untreated, may eventually produce destructive cardiovascular, neurological or granulomatous complications.
Clinical Stages of Syphilis
6. Classification of Syphilis
Syphilis is traditionally classified into primary, secondary, latent and tertiary stages.
Primary syphilis is characterised by a localised lesion at the site of inoculation.
Secondary syphilis develops following systemic dissemination and commonly produces generalised mucocutaneous manifestations.
Latent syphilis is characterised by positive serological evidence of infection without clinical symptoms or signs.
Tertiary syphilis refers to late complications, including gummatous and cardiovascular disease.
Neurosyphilis may develop at any stage and is not restricted to late disease.
The original notes describe four stages as primary, secondary, tertiary and quaternary syphilis. However, quaternary syphilis is not a standard classification in modern medicine, and latent syphilis is an important stage that should be included.
Primary Syphilis
7. Introduction to Primary Syphilis
Primary syphilis is the first clinically apparent stage of infection.
It typically develops approximately three weeks after exposure, although the incubation period varies.
The classical manifestation is a painless ulcer called a chancre, which develops at the site where Treponema pallidum entered the body.
The lesion most commonly occurs in the genital region but may also develop in the anus, rectum, mouth or other sites exposed during sexual contact.
Primary syphilis is highly infectious because the chancre contains numerous organisms.
8. Clinical Features of the Primary Chancre
The classical syphilitic chancre begins as a small papule that subsequently ulcerates.
It typically forms a round or oval ulcer with a clean base, firm or indurated edges and relatively little surrounding inflammation.
The lesion is usually painless, which is an important distinguishing feature from several other causes of genital ulceration.
However, chancres may occasionally be painful, multiple or atypical, particularly when another infection is present.
The chancre may go unnoticed if it develops inside the vagina, cervix, rectum or another less visible anatomical site.
The characteristic examination association is a painless, indurated genital ulcer with a clean base.
9. Regional Lymphadenopathy in Primary Syphilis
Primary syphilis is commonly associated with regional lymphadenopathy.
In patients with genital chancres, the inguinal lymph nodes may become enlarged.
The lymphadenopathy is typically non-tender, firm and may involve lymph nodes on both sides.
This occurs because the organism spreads through local lymphatic channels and stimulates an immune response.
The combination of a painless genital ulcer and painless regional lymphadenopathy strongly suggests primary syphilis, although laboratory confirmation is necessary.
10. Healing of the Primary Chancre
The primary chancre generally heals spontaneously within approximately three to six weeks, although healing may take longer.
The original notes describe healing within three to eight weeks, which is broadly compatible with the variable natural course.
Importantly, spontaneous healing does not indicate eradication of the infection.
Even after the chancre disappears, Treponema pallidum may remain within the body and continue disseminating.
Without treatment, the patient may subsequently develop secondary syphilis or enter a latent stage.
This explains why the disappearance of a genital ulcer must not be interpreted as evidence of cure.
11. Differential Diagnosis of Primary Syphilis
Several other conditions can produce genital ulceration.
Genital herpes, caused by herpes simplex virus, commonly produces painful vesicles that rupture into superficial ulcers.
Chancroid, caused by Haemophilus ducreyi, classically produces painful genital ulcers with tender regional lymphadenopathy.
Lymphogranuloma venereum, caused by certain serovars of Chlamydia trachomatis, may produce a small initial lesion followed by prominent lymphadenopathy or proctitis.
Traumatic ulcers and other inflammatory or malignant conditions may also resemble a chancre.
Because clinical appearances overlap, suspected syphilis requires appropriate laboratory investigation.
Secondary Syphilis
12. Introduction to Secondary Syphilis
Secondary syphilis develops when Treponema pallidum disseminates throughout the body.
It commonly appears several weeks to a few months after the primary chancre develops.
The original notes describe a generalised rash appearing six to eight weeks later, which is a useful approximate interval, although the timing varies.
Secondary syphilis may occur after the chancre has healed or while the primary lesion is still present.
This stage is characterised by widespread systemic manifestations involving the skin, mucous membranes, lymph nodes and occasionally internal organs.
13. Generalised Maculopapular Rash
The most characteristic manifestation of secondary syphilis is a generalised skin rash.
The eruption is commonly maculopapular, consisting of flat and slightly raised lesions.
A particularly important feature is involvement of the palms of the hands and soles of the feet.
The rash is often non-pruritic, although itching can occur.
Its appearance may vary considerably and can resemble viral exanthems, psoriasis, pityriasis rosea or other dermatological conditions.
The examination association is a generalised maculopapular rash involving the palms and soles.
14. Generalised Lymphadenopathy
Secondary syphilis frequently produces generalised lymphadenopathy.
Lymph nodes may become enlarged in the cervical, axillary, inguinal and other regions.
The nodes are usually firm, discrete and relatively painless.
Generalised lymphadenopathy occurs because of systemic dissemination and widespread immune activation.
The combination of generalised lymphadenopathy and a characteristic rash should raise suspicion of secondary syphilis.
15. Mucous Patches
Mucous patches are superficial, highly infectious lesions that develop on mucosal surfaces during secondary syphilis.
They may occur in the oral cavity, pharynx, genital region or other mucosal sites.
These lesions often appear as shallow, greyish-white erosions or plaques.
Because they contain numerous organisms, mucous patches can contribute to sexual transmission.
Their presence alongside a generalised rash and lymphadenopathy strongly supports secondary syphilis.
16. Condylomata Lata
Condylomata lata are broad, flat, moist lesions that occur in secondary syphilis.
They commonly develop in warm, intertriginous regions such as the perianal area, genital folds and groin.
These lesions may appear as smooth or slightly raised plaques.
Condylomata lata contain large numbers of Treponema pallidum organisms and are therefore highly infectious.
They should be distinguished from condylomata acuminata, which are genital warts caused by human papillomavirus.
Condylomata lata are associated with syphilis, whereas condylomata acuminata are associated with HPV infection.
17. Constitutional Symptoms of Secondary Syphilis
Secondary syphilis may produce systemic symptoms resembling a viral illness.
Patients may develop fever, fatigue, malaise, headache, sore throat, weight loss and muscle aches.
These symptoms reflect widespread dissemination of the organism and the host inflammatory response.
Some patients may have only mild symptoms, while others develop more extensive systemic manifestations.
Because the clinical presentation is variable, syphilis should be considered in patients with unexplained rash and systemic symptoms when epidemiological risk factors are present.
18. Syphilitic Alopecia
Secondary syphilis may occasionally cause hair loss.
A characteristic presentation is patchy, non-scarring alopecia, sometimes described as moth-eaten alopecia.
The hair loss may involve the scalp, eyebrows or other hair-bearing areas.
This manifestation results from inflammation associated with systemic treponemal infection.
Hair growth generally improves following appropriate treatment.
19. Periostitis and Arthritis
Secondary syphilis can occasionally involve the musculoskeletal system.
Periostitis refers to inflammation of the periosteum, the connective tissue covering the outer surface of bones.
Patients may experience bone pain, sometimes more prominent at night.
Syphilitic arthritis or joint inflammation may also occur, although these manifestations are less common than the characteristic rash and lymphadenopathy.
Musculoskeletal involvement reflects the systemic nature of disseminated treponemal infection.
20. Syphilitic Hepatitis
Hepatic involvement is an uncommon but recognised manifestation of secondary syphilis.
Patients may develop abnormal liver function tests, particularly a disproportionate elevation of alkaline phosphatase.
Some individuals experience hepatomegaly, abdominal discomfort or jaundice.
Syphilitic hepatitis should be considered when compatible systemic features accompany otherwise unexplained liver abnormalities.
Liver abnormalities generally improve following appropriate antibiotic treatment.
21. Syphilitic Glomerulonephritis
Renal involvement is a rare complication of secondary syphilis.
One recognised manifestation is immune-complex-mediated glomerulonephritis.
Patients may develop proteinuria, haematuria or nephrotic syndrome.
The renal disease is believed to result from immune-complex deposition within the glomeruli.
Treatment of the underlying syphilitic infection often leads to improvement in renal manifestations.
Latent Syphilis
22. Introduction to Latent Syphilis
Latent syphilis is the stage in which the patient has serological evidence of infection but no clinical manifestations of primary, secondary or tertiary syphilis.
The patient may feel entirely well despite persistent infection.
Latent syphilis may follow the resolution of primary or secondary lesions.
The absence of symptoms does not mean the organism has been eliminated.
Latent infection may persist for years if untreated.
23. Early Latent Syphilis
Early latent syphilis refers to asymptomatic infection acquired relatively recently.
Under commonly used CDC criteria, early latent syphilis is defined as infection acquired within the preceding year.
The diagnosis may be supported by documented seroconversion, a sustained fourfold increase in non-treponemal titre, recent symptoms of primary or secondary syphilis, or a clearly established recent exposure.
Early latent infection is clinically important because it indicates relatively recent acquisition.
Although sexual transmission is primarily associated with infectious lesions, early latent syphilis remains relevant to partner management and public health assessment.
24. Late Latent Syphilis
Late latent syphilis refers to asymptomatic infection that has persisted beyond the early latent period.
Patients may have no symptoms despite positive serological tests.
Non-treponemal antibody titres may decline over time, while treponemal tests often remain reactive.
Some patients with untreated late latent syphilis may eventually develop tertiary complications.
However, progression to tertiary syphilis is not inevitable.
25. Latent Syphilis of Unknown Duration
When the time of infection cannot be reliably established, the condition is classified as latent syphilis of unknown duration.
This distinction is important because treatment regimens differ according to the stage of infection.
Patients with late latent syphilis or syphilis of unknown duration generally require a longer penicillin treatment course than patients with uncomplicated early syphilis.
Clinical history, previous test results and possible exposures are used to determine the most appropriate classification.
Tertiary Syphilis
26. Introduction to Tertiary Syphilis
Tertiary syphilis refers to destructive complications that may develop years or decades after untreated infection.
The original notes describe tertiary manifestations developing three to ten years after the primary lesion.
Although this interval may occur, the onset is highly variable, and some manifestations develop much later.
Tertiary syphilis is traditionally associated with gummatous disease and cardiovascular syphilis.
Neurological complications may also occur during late infection, but neurosyphilis can develop at any stage.
27. Gummatous Syphilis
Gummatous syphilis is characterised by the formation of destructive granulomatous inflammatory lesions known as gummata.
Gummata may develop in the skin, mucous membranes, bones and internal organs.
They represent a delayed inflammatory response associated with persistent treponemal infection.
The lesions may gradually enlarge and destroy surrounding tissue.
Gummatous syphilis is less common in settings where early diagnosis and antibiotic treatment are widely available.
28. Gummata of the Skin and Mucous Membranes
Cutaneous gummata may begin as firm nodules or plaques.
As the inflammatory process progresses, central tissue destruction may lead to ulceration.
The resulting ulcers can have well-defined, punched-out appearances.
Gummata involving the palate or nasal structures may produce tissue destruction and deformity.
The original notes correctly describe gummata as granulomatous nodules that may break down into shallow punched-out ulcers.
However, the depth and appearance of ulceration vary according to the affected tissue.
29. Gummatous Involvement of Bone
Gummatous lesions may involve the periosteum or deeper bone structures.
Patients may develop chronic bone pain, swelling and destructive lesions.
The tibia, skull and other bones may be affected.
Advanced disease may produce structural deformity or pathological fractures.
Radiological findings depend on the extent of bone destruction and the associated inflammatory response.
Cardiovascular Syphilis
30. Introduction to Cardiovascular Syphilis
Cardiovascular syphilis is a late complication of untreated syphilitic infection.
It usually develops many years after the initial infection, often after a decade or longer.
The most important pathological process is syphilitic aortitis.
The ascending thoracic aorta is particularly susceptible to involvement.
Inflammation and destruction of the aortic wall can lead to aneurysm formation, aortic valve regurgitation and coronary ostial narrowing.
31. Syphilitic Aortitis
Syphilitic aortitis results from chronic inflammation involving the aortic wall.
A characteristic pathological feature is endarteritis obliterans of the vasa vasorum.
The vasa vasorum are small blood vessels that supply the walls of large arteries.
Inflammation and narrowing of these vessels reduce blood supply to the aortic media.
This produces medial injury, elastic tissue destruction and progressive weakening of the aortic wall.
The resulting damage may cause aortic dilatation and aneurysm formation.
32. Syphilitic Aortic Aneurysm
Aortic aneurysm formation is a major complication of cardiovascular syphilis.
The ascending thoracic aorta is classically affected.
Destruction of elastic tissue weakens the vessel wall and allows progressive dilatation.
Aneurysms may produce chest pain, compression of adjacent structures or complications related to aortic expansion.
Severe disease can lead to rupture, although this is less commonly encountered today because of earlier diagnosis and treatment.
The characteristic association is late syphilis with ascending thoracic aortic aneurysm.
33. Aortic Incompetence
Aortic incompetence, also called aortic regurgitation, may develop when syphilitic aortitis causes dilatation of the aortic root.
As the aortic root enlarges, the aortic valve leaflets may fail to close properly.
This allows blood to flow backward from the aorta into the left ventricle during diastole.
Patients may develop exertional breathlessness, fatigue, palpitations and signs of left ventricular volume overload.
Aortic regurgitation can eventually cause left ventricular dilatation and heart failure.
34. Coronary Ostial Stenosis
Coronary ostial stenosis is another recognised complication of cardiovascular syphilis.
Inflammation and fibrosis near the origins of the coronary arteries may narrow the coronary ostia.
This can reduce blood flow to the myocardium.
Patients may develop angina or myocardial ischaemia.
Coronary ostial stenosis is particularly associated with syphilitic involvement of the aortic root.
Neurosyphilis
35. Introduction to Neurosyphilis
Neurosyphilis occurs when Treponema pallidum involves the central nervous system.
It is important to recognise that neurosyphilis can develop at any stage of syphilitic infection, including early disease.
The original notes place neurological complications under late or quaternary syphilis.
This reflects a traditional classification but does not fully represent modern understanding.
Neurosyphilis may involve the meninges, cerebral blood vessels, brain parenchyma, spinal cord or posterior spinal nerve roots.
Its manifestations depend on the structures affected.
36. Early Neurosyphilis
Early neurosyphilis may develop within months or years of infection.
It commonly involves the meninges or cerebral blood vessels.
Patients may develop headache, neck stiffness, cranial nerve abnormalities or other neurological symptoms.
Some individuals have asymptomatic central nervous system involvement.
Symptomatic meningeal or meningovascular disease requires specific diagnostic evaluation and intravenous antibiotic treatment.
37. Meningovascular Syphilis
Meningovascular syphilis is characterised by inflammation involving the meninges and blood vessels of the central nervous system.
A major pathological feature is inflammatory narrowing of cerebral arteries.
This can reduce cerebral blood flow and cause ischaemic stroke.
Patients may develop headache, focal neurological deficits, cranial nerve palsies or seizures.
Stroke in a relatively young patient with relevant risk factors may raise suspicion of meningovascular syphilis.
The important association is syphilitic arteritis causing cerebral ischaemia or stroke.
38. Tabes Dorsalis
Tabes dorsalis is a late manifestation of neurosyphilis involving degeneration of the posterior columns and posterior nerve roots of the spinal cord.
The posterior columns normally transmit vibration sense and conscious proprioception.
Damage to these pathways produces sensory ataxia and impaired joint position sense.
Patients may develop an unsteady gait that worsens when visual guidance is removed.
A positive Romberg sign is characteristic of impaired proprioceptive function.
39. Clinical Features of Tabes Dorsalis
Patients with tabes dorsalis may experience sudden, severe, stabbing pains known as lightning pains.
These pains commonly involve the lower limbs.
Loss of proprioception produces sensory ataxia and an unstable gait.
Deep tendon reflexes, particularly at the knees and ankles, may be reduced or absent.
Bladder dysfunction and other autonomic abnormalities may occur.
Some patients develop neuropathic joint destruction, known as Charcot arthropathy.
The classical examination association is lightning pains, sensory ataxia, absent reflexes and a positive Romberg sign.
40. General Paresis of the Insane
General paresis of the insane is a historical term for a late form of parenchymatous neurosyphilis.
It is also called general paresis or paretic neurosyphilis.
The condition results from chronic infection and inflammation involving the cerebral cortex.
Patients may develop progressive cognitive decline, behavioural changes and psychiatric symptoms.
The original notes describe dementia, tremor and spastic paralysis.
These manifestations may occur, although the clinical presentation is variable and may also include personality changes, impaired judgement, dysarthria and other neurological abnormalities.
41. Clinical Features of General Paresis
General paresis may initially produce subtle personality or behavioural changes.
Patients may develop irritability, emotional instability, impaired concentration and deterioration in memory.
Progressive disease can lead to dementia, psychiatric disturbances and loss of normal social functioning.
Neurological findings may include tremor, dysarthria, abnormal reflexes and motor dysfunction.
Without treatment, the condition may progress to severe neurological disability.
42. Argyll Robertson Pupil
The Argyll Robertson pupil is a classical neurological sign associated with neurosyphilis.
It is characterised by pupils that are usually small and irregular and demonstrate light-near dissociation.
This means the pupils constrict poorly or not at all in response to light but retain constriction during near accommodation.
The traditional description is that the pupils accommodate but do not react.
This finding is classically associated with neurosyphilis, particularly tabes dorsalis, although it is not present in every patient.
It should not be regarded as a specific diagnostic feature of meningovascular syphilis alone.
43. Ocular Syphilis
Ocular syphilis can occur at any stage of infection.
It may involve almost any ocular structure, including the uveal tract, retina and optic nerve.
Uveitis is a particularly important manifestation.
Patients may develop blurred vision, eye pain, redness, photophobia or visual loss.
Ocular syphilis requires urgent assessment because delayed treatment may result in permanent visual impairment.
Treatment generally follows neurosyphilis regimens, even when cerebrospinal fluid findings are normal.
44. Otosyphilis
Otosyphilis refers to syphilitic involvement of the auditory or vestibular system.
Patients may develop sensorineural hearing loss, tinnitus or vertigo.
Hearing loss may be sudden or progressive and may affect one or both ears.
Otosyphilis can occur at different stages of infection.
Prompt treatment is important because auditory damage may become irreversible.
Diagnosis of Syphilis
45. Direct Demonstration of Treponema pallidum
Direct detection of Treponema pallidum can establish infection when suitable lesion material is available.
The original notes describe identification of the spirochaete in fluid obtained from a chancre or ulcerated secondary lesion.
This is a recognised diagnostic approach.
Dark-field microscopy may demonstrate motile spirochaetes in specimens obtained from suitable lesions.
However, dark-field microscopy requires specialised expertise and is not widely available in many modern clinical laboratories.
Molecular testing, including polymerase chain reaction (PCR), may be used where validated assays are available.
46. Dark-Field Microscopy
Dark-field microscopy is a specialised technique used to visualise thin organisms that are difficult to detect using ordinary light microscopy.
In suspected syphilis, material from an active lesion may be examined for characteristic motile spirochaetes.
The organism demonstrates a slender, spiral shape and distinctive movement.
A positive result from an appropriate lesion can provide direct evidence of infection.
However, a negative result does not exclude syphilis because organism numbers, specimen quality and operator expertise influence sensitivity.
Dark-field examination of oral lesions is generally unsuitable because non-pathogenic oral spirochaetes can resemble Treponema pallidum.
47. Serological Diagnosis
Serological testing is the mainstay of syphilis diagnosis in most healthcare settings.
Tests are divided into non-treponemal and treponemal categories.
Non-treponemal tests detect antibodies associated with infection-related lipid antigens and are useful for monitoring treatment response.
Treponemal tests detect antibodies directed against Treponema pallidum antigens and provide evidence of current or previous infection.
A combination of both types is usually necessary for accurate interpretation.
48. VDRL Test
The Venereal Disease Research Laboratory (VDRL) test is a non-treponemal serological test.
It detects antibodies that react with cardiolipin-containing antigens.
VDRL may be negative during very early primary syphilis because antibodies have not yet developed sufficiently.
It is generally highly sensitive during secondary syphilis.
Following successful treatment, VDRL titres usually decline.
Quantitative VDRL results are therefore useful for assessing treatment response and identifying possible reinfection.
49. TPHA Test
The Treponema pallidum haemagglutination assay (TPHA) is a treponemal test.
It detects antibodies directed against treponemal antigens.
TPHA is generally positive during established syphilis but may remain negative during the earliest stage of infection.
After successful treatment, TPHA commonly remains positive for many years or throughout life.
Therefore, TPHA is useful for establishing evidence of previous exposure but is not suitable for routine monitoring of treatment effectiveness.
50. FTA-ABS Test
The fluorescent treponemal antibody absorption test (FTA-ABS) is another treponemal serological investigation.
It uses immunofluorescence to detect antibodies against Treponema pallidum.
FTA-ABS may become positive relatively early in infection.
However, like other treponemal tests, it often remains reactive following successful treatment.
Consequently, FTA-ABS cannot reliably distinguish active infection from previously treated disease.
Modern laboratories increasingly use automated treponemal immunoassays instead of FTA-ABS.
51. Interpretation of Syphilis Serology
A positive VDRL or RPR together with a positive treponemal test supports the diagnosis of current or previous syphilis.
A negative VDRL with a positive treponemal test may occur after successful treatment, during very early infection or in some cases of late untreated syphilis.
A positive VDRL with a negative treponemal test may represent a biological false-positive reaction.
Both tests may be negative during very early primary syphilis.
Therefore, laboratory findings must be interpreted alongside clinical presentation, exposure history and previous treatment.
52. Diagnosis of Neurosyphilis
Neurosyphilis is diagnosed using a combination of clinical findings, serum serology and cerebrospinal fluid investigations.
Lumbar puncture may be indicated in patients with neurological signs or symptoms suggestive of neurosyphilis.
Cerebrospinal fluid abnormalities may include lymphocytic pleocytosis and elevated protein concentration.
A reactive CSF-VDRL test in an uncontaminated specimen is highly specific for neurosyphilis in the appropriate clinical context.
However, CSF-VDRL is not sufficiently sensitive to exclude neurosyphilis when negative.
CSF treponemal tests may be useful in selected cases, although interpretation requires care.
Treatment of Syphilis
53. Penicillin as the Treatment of Choice
Penicillin G is the preferred treatment for syphilis.
The specific formulation, route and duration depend on the stage of infection and the presence of neurological, ocular or auditory involvement.
Penicillin acts by inhibiting bacterial cell wall synthesis.
It binds to penicillin-binding proteins and interferes with peptidoglycan cross-linking.
This disrupts bacterial cell wall integrity and leads to bacterial death.
Treponema pallidum remains highly susceptible to penicillin, making it the cornerstone of syphilis treatment.
54. Treatment of Primary, Secondary and Early Latent Syphilis
Uncomplicated primary, secondary and early latent syphilis are generally treated with a single intramuscular dose of benzathine penicillin G, 2.4 million units, in adults.
Benzathine penicillin G is a long-acting formulation that maintains therapeutic concentrations over an extended period.
Treatment aims to eradicate the organism, prevent progression and reduce transmission.
Follow-up serological testing is necessary to assess response.
Alternative treatments may be considered in selected non-pregnant patients with penicillin allergy, but they require appropriate clinical assessment and follow-up.
55. Treatment of Late Latent Syphilis
Late latent syphilis and latent syphilis of unknown duration generally require a longer treatment course.
The usual adult regimen is benzathine penicillin G, 2.4 million units intramuscularly once weekly for three weeks.
This provides a total dose of 7.2 million units.
The prolonged regimen is used because the duration of infection is longer or uncertain.
Treatment decisions should follow the applicable clinical guidelines and consider previous treatment history.
56. Treatment of Tertiary Syphilis
Tertiary syphilis without neurosyphilis is generally treated with benzathine penicillin G using the three-week regimen.
However, patients with neurological symptoms or findings require evaluation for neurosyphilis.
Cardiovascular syphilis also requires specialist assessment because structural complications such as aneurysms or aortic regurgitation may need additional management.
Antibiotic treatment eliminates the infection but may not reverse established anatomical damage.
57. Treatment of Neurosyphilis
Neurosyphilis requires a penicillin regimen capable of achieving effective concentrations within the cerebrospinal fluid.
The preferred treatment is aqueous crystalline penicillin G administered intravenously for 10–14 days.
The usual adult total daily dose is 18–24 million units, administered as divided doses or continuous infusion.
This regimen is also used for ocular syphilis and otosyphilis.
Intramuscular benzathine penicillin alone is inadequate for treating neurosyphilis because it does not reliably achieve sufficient cerebrospinal fluid concentrations.
58. Treatment During Pregnancy
Penicillin G is the only reliably effective treatment for syphilis during pregnancy that treats fetal infection and prevents congenital syphilis.
The regimen depends on the maternal stage of infection.
Pregnant patients with penicillin allergy should undergo appropriate desensitisation followed by penicillin treatment.
Alternative antibiotics are not considered equivalent for preventing or treating fetal syphilis.
Timely diagnosis and treatment during pregnancy are essential to reduce the risks of miscarriage, stillbirth and congenital infection.
59. Jarisch–Herxheimer Reaction
The Jarisch–Herxheimer reaction is an acute inflammatory response that may occur shortly after antibiotic treatment of syphilis.
It is thought to result from the host inflammatory response to treponemal components released or exposed during treatment.
Symptoms may include fever, chills, headache, muscle aches and temporary worsening of existing lesions.
The reaction usually begins within the first 24 hours after treatment and is generally self-limiting.
It is not the same as an allergic reaction to penicillin.
In pregnancy, the reaction may occasionally provoke uterine contractions or fetal distress, making appropriate clinical monitoring important.
60. Monitoring Treatment Response
The response to syphilis treatment is assessed using quantitative non-treponemal tests such as VDRL or RPR.
Successful treatment generally produces a progressive decline in antibody titres.
A fourfold decline is an important marker of serological response.
For example, a decrease from 1:32 to 1:8 represents a fourfold reduction.
The expected timing depends on the stage of syphilis and patient-specific factors.
Treponemal tests such as TPHA and FTA-ABS are not generally used to monitor treatment response because they may remain positive for life.
Congenital Syphilis
61. Introduction to Congenital Syphilis
Congenital syphilis develops when Treponema pallidum crosses the placenta and infects the fetus.
Transmission can occur during pregnancy, particularly when maternal syphilis is untreated.
Congenital infection may result in miscarriage, stillbirth, premature delivery or neonatal disease.
Some infected infants are asymptomatic at birth but develop manifestations later.
Early antenatal screening and appropriate maternal penicillin treatment are the most effective preventive measures.
62. Early Congenital Syphilis
Early congenital syphilis generally refers to manifestations occurring during the first two years of life.
Clinical findings may include persistent nasal discharge, commonly called snuffles, which can contain infectious organisms.
Other manifestations include rash, hepatosplenomegaly, jaundice, anaemia and bone abnormalities.
Some infants develop periostitis or osteochondritis, causing painful or reduced limb movement.
Prompt diagnosis and treatment are important to prevent progression.
63. Late Congenital Syphilis
Late congenital syphilis may produce characteristic skeletal, dental, ocular and auditory abnormalities.
Important findings include Hutchinson teeth, interstitial keratitis and sensorineural hearing loss.
These three manifestations form the classical Hutchinson triad.
Other features may include saddle-nose deformity, frontal bossing and sabre tibia.
Late manifestations reflect the consequences of congenital infection and associated tissue injury.
Clinical Comparison of Syphilis Stages
64. Primary Syphilis – Clinical Pattern
Primary syphilis is characterised by a localised chancre at the site of inoculation.
The ulcer is classically painless, indurated and associated with non-tender regional lymphadenopathy.
The lesion usually appears approximately three weeks after exposure.
It may heal spontaneously without treatment, but the infection can persist and progress.
65. Secondary Syphilis – Clinical Pattern
Secondary syphilis develops following systemic dissemination of Treponema pallidum.
The classical presentation includes a generalised maculopapular rash involving the palms and soles.
Generalised lymphadenopathy, mucous patches, condylomata lata and systemic symptoms may occur.
Less common manifestations include periostitis, arthritis, hepatitis and glomerulonephritis.
66. Latent Syphilis – Clinical Pattern
Latent syphilis is characterised by positive serological evidence of infection without clinical symptoms.
Patients may remain asymptomatic for prolonged periods.
Treponemal tests are usually reactive, while non-treponemal titres vary.
Untreated infection may remain latent or progress to late complications.
67. Tertiary Syphilis – Clinical Pattern
Tertiary syphilis may develop years or decades after untreated infection.
Gummatous disease produces destructive granulomatous lesions involving the skin, mucous membranes, bones or other organs.
Cardiovascular syphilis may produce aortitis, ascending aortic aneurysm, aortic regurgitation and coronary ostial stenosis.
Neurological manifestations may also occur, although neurosyphilis is not restricted to the tertiary stage.
68. Neurosyphilis – Clinical Pattern
Neurosyphilis may involve the meninges, cerebral vessels, brain or spinal cord.
Meningovascular syphilis may cause headache, cranial nerve palsies and stroke.
Tabes dorsalis produces lightning pains, sensory ataxia, loss of proprioception and absent deep tendon reflexes.
General paresis produces progressive cognitive and behavioural deterioration.
Argyll Robertson pupils demonstrate impaired light response with preserved near response.
Important Corrections to the Original Notes
69. Modern Classification of Syphilis
The original notes classify syphilis into primary, secondary, tertiary and late or quaternary stages.
Modern classification instead recognises primary, secondary, latent and tertiary syphilis.
Neurosyphilis, ocular syphilis and otosyphilis may occur at any stage.
The term quaternary syphilis is not routinely used in modern clinical practice.
70. Timing of Clinical Stages
The original notes describe secondary syphilis developing six to eight weeks after the primary lesion, tertiary syphilis after three to ten years and late disease after ten to twenty years.
These intervals are useful historical approximations but should not be treated as fixed timelines.
Secondary syphilis may overlap with primary syphilis.
Tertiary manifestations may develop after variable periods, sometimes decades after infection.
Neurosyphilis can occur during early or late infection.
71. Diagnosis of Syphilis
The original notes emphasise direct demonstration of the organism from a chancre or secondary lesion.
Although direct detection can establish infection, serological testing is the principal diagnostic approach in most modern healthcare settings.
Direct methods, such as dark-field microscopy or validated molecular tests, are useful when available.
A combination of non-treponemal and treponemal serology is generally required.
72. Treatment of Syphilis
The original statement that syphilis is treated with penicillin is correct.
However, treatment differs according to disease stage.
Primary, secondary and early latent syphilis usually require a single intramuscular dose of benzathine penicillin G.
Late latent syphilis and tertiary syphilis without neurosyphilis generally require three weekly intramuscular doses.
Neurosyphilis, ocular syphilis and otosyphilis require intravenous aqueous crystalline penicillin G.
Key Clinical Pattern
The most important feature of syphilis is its progression from localised infection to systemic dissemination, asymptomatic latency and potentially destructive late complications.
Treponema pallidum → Spirochaete responsible for syphilis.
Primary syphilis → Painless, indurated genital chancre with regional lymphadenopathy.
Secondary syphilis → Generalised maculopapular rash involving palms and soles, with generalised lymphadenopathy.
Latent syphilis → Positive serology without clinical symptoms.
Tertiary syphilis → Gummata and cardiovascular complications.
Cardiovascular syphilis → Aortitis, ascending aortic aneurysm, aortic regurgitation and coronary ostial stenosis.
Tabes dorsalis → Posterior column and dorsal root damage, lightning pains, sensory ataxia and absent reflexes.
General paresis → Progressive dementia, behavioural changes and neurological deterioration.
Argyll Robertson pupils → Accommodate but do not react to light.
VDRL/RPR → Non-treponemal tests used to monitor treatment response.
TPHA/FTA-ABS → Treponemal tests that often remain positive after successful treatment.
Penicillin G → Treatment of choice for syphilis, with the regimen determined by disease stage.
For examinations, remember the classical progression of untreated syphilis: painless chancre → generalised rash involving palms and soles → latent infection → possible gummatous or cardiovascular disease. Neurosyphilis can occur at any point in this progression, and appropriate penicillin treatment is essential to prevent serious complications.